A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma
NCT00855517
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Sponsor's decision
Conditions
Glaucoma
Ocular Hypertension
Interventions
DRUG:
Latanoprost-PPDS
Sponsor
Mati Therapeutics Inc.